Skip to main content

Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes

Objective

HYMADE focuses on the development of capsules and engineered colloidal particles for drug delivery combining mesoporous colloids, the Layer by Layer (LbL) technique and virosomes. The capsules and particles have potential applications in cancer and inflammatory diseases such as rheumatoid arthritis and uveitis.
The project is based on the secondments of Early Stage Researchers and Experienced Researchers and networking and training activities between European and non European academic institutions.
HYMADE aims to profit from the combination of hybrid materials to fabricate advanced drug delivery systems with controlled release and targeting efficiency of biological entities. The project also aims to gain understanding of the self assembly process of hybrid materials and the transport properties of the drug delivery systems.The biological fate, drug release, degradation and therapeutical efficiency of the drug delivery systems will be studied in vitro and in vivo with state of the art imaging techniques. To achieve these goals we have gathered an international multidisciplinary team with scientists at the forefront of Material Science, Self assembly, Physics, Chemistry, Biophysics and Imaging from Germany, Austria, France and Spain on the European side and from United States of America, Argentina and Armenia on the non European side.

Field of science

  • /medical and health sciences/health sciences/inflammatory diseases
  • /natural sciences/biological sciences/biophysics
  • /medical and health sciences/clinical medicine/oncology/cancer
  • /natural sciences/physical sciences/theoretical physics/particles
  • /social sciences/social and economic geography/transport

Call for proposal

H2020-MSCA-RISE-2014
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE
Address
Paseo Miramon 182, Parque Tecnologico De San Sebastian Edificio Empresarial C
20009 San Sebastian
Spain
Activity type
Research Organisations
EU contribution
€ 747 000

Participants (3)

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
Austria
EU contribution
€ 243 000
Address
Giefinggasse 4
1210 Wien
Activity type
Research Organisations
UNIVERSITAET LEIPZIG

Participation ended

Germany
EU contribution
€ 157 500
Address
Ritterstrasse 26
04109 Leipzig
Activity type
Higher or Secondary Education Establishments
SORBONNE UNIVERSITE
France
EU contribution
€ 72 000
Address
21 Rue De L'ecole De Medecine
75006 Paris
Activity type
Higher or Secondary Education Establishments

Partners (5)

UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN
United States
Address
South Street 3003 1068
46109 1274 Ann Arbor
Activity type
Higher or Secondary Education Establishments
Yerevan State University
Armenia
Address
Alex Manoogian Street 1
0025 Yerevan
Activity type
Higher or Secondary Education Establishments
COMISION NACIONAL DE ENERGIA ATOMICA
Argentina
Address
Avda. Del Libertador 8250
1429 Buenos Aires
Activity type
Research Organisations
CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET)
Argentina
Address
Godoy Cruz 2290
C1425FQB Buenos Aires
Activity type
Research Organisations
UNIVERSIDAD NACIONAL DE GENERAL SAN MARTIN
Argentina
Address
Martin De Irigoyen 3100
1650 San Martin Buenos Aires
Activity type
Higher or Secondary Education Establishments